Authors: BALLOW CH JONES RN JOHNSON DM DEINHART JA SCHENTAG JJ TRITSCH M ELLIS S BURGER J COLE E VENEZIA R GEORGE M WOLF D SLIFKIN M DEPALMA J RUDRIK J SULLIVAN K LEWIS G DOOLEY G SAWICKI R DESIDERIO D LOUMA R MOTYL M RUFFIN L TORRESAN J DUNAWAY G KECK G TRUITT L BRECHER S VANENK R WHELEN C FADER R WHISLER G JENKINS S THACKER D DAMATO R BUCK R BUESCHER S LAMBERT K TRISTRAM D KEHL S LAWSON C WASHINGTON J ROBERTSON K BEALL A PADGETT L RAHMAN L RIDDLE G DELLALATTA P MARCON M NORTHERN I MAGALLON B KOCKA F RHOADS S MORTON V GRAVES J RYBAK M BROWN W SOSNOWSKI K KHALIFE W GIGER O GIPSON R PARK C HERNANDEZ S OLDING T TAYLOR D MITCHELL M HOGAN B SATHER P HORNER A ROGERS P SAUTTER R HOBAN D MARTENS M APPELBAUM P LATINO J POON P HOUK J WALSH W CONDOTTI P REYNOLDS J HERRING A MADISON B FREUNZILICH L FUSCO J TURNER N ISENBERG H SWEENEY L GAUTHIERS S DAY T WRIGHT L ALBERT S AIROLDI T TAY T TAUBENHEIM D WILLIAMS C SELLEN T DAVENPORT M DOWNING L DENYS G AHMED M DAVIS S LAND G BOYLE J TALLENT S SHARP S PENDOWSKI C KLEIN R NEWTON J CZEREPUSZKO D STEINKRAUS G PUTTLITZ D WASILAUSKAS B PHILLIPS H VENTURELLA J OCONNELL A COLLINS C IMBORIBOON H PANKEY G VORA R BACHMANN N SOUTHERN P FAIRBANKS L HOWARD J LEBAR W THOMAS E VELAZCO D WEINSTEIN M VELLETRI K BETZ I HAYDEN M HOFFMAN M WAEFORD F GOODWIN J THACKERAY A TOMLINSON R CUCCHIARA F HUDAK P JONES D SCHECHTERLY C STELLMACH J NORDLOF V MORTENSEN J DICKSON J GISH N CAVALIERI S KENYON V RAWLING R MATTICS C STROZEWSKI C ALIKAHN M KROH H NGO T OAKES G BAEKERHOVDE L MARKOVIC M TAMME L GORDON M HAGEAGE G FILE T FORBES B HUBER T CHESLEY D HAMWAY S WAITES K MONAHAN J JONES R OVERMAN S SNYDER J SCHWALBE R HUMPHRIES J OVERTURF G WANGER A CARROLL K FRITSCHE T WELCH D FISHER C DAILY J GRENDISA S REIMER L GAYDOS M SEWELL D JENSEN B PFLEGER S SEIPLE J JOVELLANOS P VANHORN K CARRO A FULLER D BOSTIC G

Citation: Ch. Ballow et al., COMPARATIVE IN-VITRO ASSESSMENT OF SPARFLOXACIN ACTIVITY AND SPECTRUMUSING RESULTS FROM OVER 14,000 PATHOGENS ISOLATED AT 190 MEDICAL-CENTERS IN THE USA, Diagnostic microbiology and infectious disease, 29(3), 1997, pp. 173-186

Authors: NEWSOM RW MARTIN TJ WASILAUSKAS B

Citation: Rw. Newsom et al., CAT-SCRATCH DISEASE DIAGNOSED SEROLOGICALLY USING AN ENZYME-IMMUNOASSAY IN A PATIENT WITH NEURORETINITIS, Archives of ophthalmology, 114(4), 1996, pp. 493-494

Authors: JONES RN KEHRBERG EN ERWIN ME ANDERSON SC BEAVIS K BERMAN M BOURBEAU P SINNOTT J CANAWATI H CAVALIERI S COCKERILL F DELLALATTA P DENYS G DOERN G FORBES B GAMBLE S GOODMAN N HAUGEN T HINDLER J HUMPHRIES J JOSEPHSON S KAUFFMAN C LIBERTINE C MAUNEY C METCHOCK B MICHELSON P MURRAY P NEEDHAM C OELSCHDAEGER R PRICE M SACEANU C SCHWALBE R SEGRETI J SEWELL D SIERRA M SLIFKIN M SNYDMAN D SOUTHERN P SPIEGEL C STEELEMOORE L STEIN G STRATTON C WANGER A WASHINGTON J WASILAUSKAS B WEINSTEIN M

Citation: Rn. Jones et al., PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 203-215

Authors: WASILAUSKAS B MORRELL R

Citation: B. Wasilauskas et R. Morrell, INHIBITORY EFFECT OF THE ISOLATOR BLOOD CULTURE SYSTEM ON GROWTH OF MYCOBACTERIUM-AVIUM MYCOBACTERIUM-INTRACELLULARE IN BACTEC 12B BOTTLES, Journal of clinical microbiology, 32(3), 1994, pp. 654-657

Authors: MORRELL R WASILAUSKAS B WINSLOW R

Citation: R. Morrell et al., EXPERT-SYSTEMS, American journal of hospital pharmacy, 51(16), 1994, pp. 2022-2030

Authors: MORRELL R WASILAUSKAS B WINSLOW R

Citation: R. Morrell et al., PERSONAL COMPUTER-BASED EXPERT-SYSTEM FOR QUALITY ASSURANCE OF ANTIMICROBIAL THERAPY, American journal of hospital pharmacy, 50(10), 1993, pp. 2067-2073